Serveur d'exploration sur la COVID en France - Analysis (France)

Index « Auteurs » - entrée « P-M Llorca »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
P-A Bolze < P-M Llorca < P-Y Royer  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
000036 (2020) H. Javelot [France] ; P-M Llorca [France] ; D. Drapier [France] ; E. Fakra [France] ; C. Hingray [France] ; G. Meyer [France] ; S. Dizet [France] ; A. Egron [France] ; C. Straczek [France] ; M. Roser [France] ; M. Masson [France] ; R. Gaillard [France] ; P. Fossati [France] ; E. Haffen [France][Informations on psychotropics and their adaptations for patients suffering from mental disorders in France during the SARS-CoV-2 epidemic].
000045 (2020) A. Chevance [France] ; D. Gourion [France] ; N. Hoertel [France] ; P-M Llorca [France] ; P. Thomas [France] ; R. Bocher [France] ; M-R Moro [France] ; V. Laprévote [France] ; A. Benyamina [France] ; P. Fossati [France] ; M. Masson [France] ; E. Leaune [France] ; M. Leboyer [France] ; R. Gaillard [France][Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review].
000169 (2020) A. Chevance [France] ; D. Gourion [France] ; N. Hoertel [France] ; P-M Llorca [France] ; P. Thomas [France] ; R. Bocher [France] ; M-R Moro [France] ; V. Laprévote [France] ; A. Benyamina [France] ; P. Fossati [France] ; M. Masson [France] ; E. Leaune [France] ; M. Leboyer [France] ; R. Gaillard [France]Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review.

List of associated KwdEn.i

Nombre de
documents
Descripteur
3Betacoronavirus (MeSH)
3Coronavirus Infections (epidemiology)
3France (epidemiology)
3Humans (MeSH)
3Mental Disorders (epidemiology)
3Pandemics (MeSH)
3Pneumonia, Viral (epidemiology)
2Age Factors (MeSH)
2Aged, 80 and over (MeSH)
2Antiviral Agents (therapeutic use)
2Comorbidity (MeSH)
2Coronavirus Infections (psychology)
2Drug Interactions (MeSH)
2Hospitals, Psychiatric (organization & administration)
2Mental Disorders (therapy)
2Pneumonia, Viral (psychology)
2Stress Disorders, Post-Traumatic (etiology)
2Stress Disorders, Post-Traumatic (therapy)
2Suicide (prevention & control)
1Aftercare (MeSH)
1Aged (MeSH)
1Antiviral Agents (adverse effects)
1Antiviral Agents (pharmacokinetics)
1Biotransformation (MeSH)
1Cardiovascular Diseases (chemically induced)
1Child (MeSH)
1Cognition Disorders (epidemiology)
1Cognition Disorders (therapy)
1Continuity of Patient Care (MeSH)
1Continuity of Patient Care (organization & administration)
1Coronavirus Infections (drug therapy)
1Cytochrome P-450 CYP1A2 (metabolism)
1Epidemics (MeSH)
1Fever (chemically induced)
1Gastrointestinal Diseases (chemically induced)
1Hospital Units (organization & administration)
1Hospitals, Psychiatric (standards)
1Hospitals, Psychiatric (statistics & numerical data)
1Infection Control (methods)
1Mental Disorders (chemically induced)
1Mental Disorders (drug therapy)
1Mental Disorders (etiology)
1Mental Disorders (prevention & control)
1Mental Health (MeSH)
1Mental Health Services (organization & administration)
1Mental Health Services (supply & distribution)
1Patient Care Team (MeSH)
1Patient Compliance (MeSH)
1Pharmaceutical Preparations (supply & distribution)
1Pneumonia, Viral (drug therapy)
1Prisoners (psychology)
1Psychotic Disorders (epidemiology)
1Psychotic Disorders (therapy)
1Psychotropic Drugs (administration & dosage)
1Psychotropic Drugs (adverse effects)
1Psychotropic Drugs (pharmacokinetics)
1Psychotropic Drugs (therapeutic use)
1Quarantine (psychology)
1Quarantine (statistics & numerical data)
1Respiration Disorders (chemically induced)
1Risk Assessment (MeSH)
1Risk Factors (MeSH)
1Smoking Cessation (MeSH)
1Stress Disorders, Post-Traumatic (epidemiology)
1Stress, Psychological (etiology)
1Stress, Psychological (therapy)
1Substance-Related Disorders (epidemiology)
1Substance-Related Disorders (therapy)
1Suicide (statistics & numerical data)
1Symptom Assessment (MeSH)
1Vulnerable Populations (MeSH)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "P-M Llorca" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "P-M Llorca" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    P-M Llorca
}}

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021